Cargando…
Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study
BACKGROUND: Adverse drug reactions and lack of therapeutic efficacy associated with currently prescribed pharmacotherapeutics may be attributed, in part, to inter-individual variability in drug metabolism. Studies on the pharmacogenetics of Cytochrome P450 (CYP) enzymes offer insight into this varia...
Autores principales: | Dodgen, Tyren M, Hochfeld, Warren E, Fickl, Heidi, Asfaha, Sahle M, Durandt, Chrisna, Rheeder, Paul, Drögemöller, Britt I, Wright, Galen E B, Warnich, Louise, Labuschagne, Christiaan DJ, van Schalkwyk, Antoinette, Gaedigk, Andrea, Pepper, Michael S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3605304/ https://www.ncbi.nlm.nih.gov/pubmed/23356658 http://dx.doi.org/10.1186/1471-2350-14-20 |
Ejemplares similares
-
Analytical Validation of AmpliChip p53 Research Test for Archival Human Ovarian FFPE Sections
por: Marton, Matthew J., et al.
Publicado: (2015) -
Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation
por: Warnich, Louise, et al.
Publicado: (2011) -
An In Vitro and In Vivo Comparison of Osteogenic Differentiation of Human Mesenchymal Stromal/Stem Cells
por: Mollentze, Jamie, et al.
Publicado: (2021) -
Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade
por: Alessandrini, Marco, et al.
Publicado: (2016) -
Risperidone-associated adverse drug reactions and CYP2D6 polymorphisms in a South African cohort
por: Dodgen, Tyren M., et al.
Publicado: (2015)